nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—Diphenidol—Bepridil—hypertension	0.327	1	CrCrCtD
Procyclidine—CHRM4—Nicardipine—hypertension	0.165	0.375	CbGbCtD
Procyclidine—CHRM3—Nicardipine—hypertension	0.103	0.234	CbGbCtD
Procyclidine—CHRM1—Nicardipine—hypertension	0.0897	0.204	CbGbCtD
Procyclidine—CHRM2—Nicardipine—hypertension	0.0827	0.188	CbGbCtD
Procyclidine—CHRM3—Signaling by GPCR—RHOA—hypertension	1.16e-05	5.01e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AVP—hypertension	1.16e-05	5.01e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNAS—hypertension	1.16e-05	5.01e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—POMC—hypertension	1.16e-05	5e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNAS—hypertension	1.16e-05	4.99e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3R1—hypertension	1.16e-05	4.98e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—INS—hypertension	1.15e-05	4.97e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—RHOA—hypertension	1.15e-05	4.96e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3R1—hypertension	1.15e-05	4.96e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNAS—hypertension	1.15e-05	4.94e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARA—hypertension	1.14e-05	4.93e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3R1—hypertension	1.14e-05	4.91e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOB—hypertension	1.14e-05	4.9e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL2—hypertension	1.14e-05	4.89e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOB—hypertension	1.13e-05	4.89e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTK2—hypertension	1.13e-05	4.88e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTK2—hypertension	1.13e-05	4.87e-05	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CXCL8—hypertension	1.13e-05	4.86e-05	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CXCL8—hypertension	1.12e-05	4.85e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOB—hypertension	1.12e-05	4.84e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EDN1—hypertension	1.12e-05	4.82e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTK2—hypertension	1.12e-05	4.82e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EDN1—hypertension	1.12e-05	4.81e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IGF1—hypertension	1.12e-05	4.81e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT2—hypertension	1.12e-05	4.81e-05	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CXCL8—hypertension	1.11e-05	4.8e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL5—hypertension	1.11e-05	4.79e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—EGFR—hypertension	1.11e-05	4.78e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AGT—hypertension	1.11e-05	4.77e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL5—hypertension	1.11e-05	4.77e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EDN1—hypertension	1.11e-05	4.76e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL5—hypertension	1.1e-05	4.73e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CALM1—hypertension	1.09e-05	4.69e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LPL—hypertension	1.09e-05	4.68e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—APOE—hypertension	1.09e-05	4.68e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LPL—hypertension	1.08e-05	4.67e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—H2AFX—hypertension	1.08e-05	4.65e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDGFRB—hypertension	1.08e-05	4.64e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RPS6KB1—hypertension	1.08e-05	4.64e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CAV1—hypertension	1.08e-05	4.63e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—H2AFX—hypertension	1.08e-05	4.63e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDGFRB—hypertension	1.07e-05	4.62e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RPS6KB1—hypertension	1.07e-05	4.62e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—APOA1—hypertension	1.07e-05	4.62e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LPL—hypertension	1.07e-05	4.62e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—H2AFX—hypertension	1.07e-05	4.59e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADCY5—hypertension	1.06e-05	4.58e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RPS6KB1—hypertension	1.06e-05	4.58e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDGFRB—hypertension	1.06e-05	4.58e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADCY5—hypertension	1.06e-05	4.57e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SERPINE1—hypertension	1.06e-05	4.57e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCG—hypertension	1.06e-05	4.55e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCG—hypertension	1.05e-05	4.54e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADCY5—hypertension	1.05e-05	4.52e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ITGB3—hypertension	1.05e-05	4.52e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCA—hypertension	1.05e-05	4.52e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ITGB3—hypertension	1.05e-05	4.51e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCA—hypertension	1.05e-05	4.51e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCG—hypertension	1.04e-05	4.49e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—YWHAZ—hypertension	1.04e-05	4.48e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—YWHAZ—hypertension	1.04e-05	4.47e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ITGB3—hypertension	1.04e-05	4.46e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCA—hypertension	1.04e-05	4.46e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NGF—hypertension	1.03e-05	4.43e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SPP1—hypertension	1.03e-05	4.43e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—YWHAZ—hypertension	1.03e-05	4.43e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—FGF2—hypertension	1.03e-05	4.42e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SPP1—hypertension	1.03e-05	4.42e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NGF—hypertension	1.03e-05	4.42e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CXCL8—hypertension	1.02e-05	4.41e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RHOA—hypertension	1.02e-05	4.41e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CXCL8—hypertension	1.02e-05	4.4e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SPP1—hypertension	1.02e-05	4.38e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NGF—hypertension	1.02e-05	4.38e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NOS3—hypertension	1.01e-05	4.36e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3R1—hypertension	1.01e-05	4.36e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CXCL8—hypertension	1.01e-05	4.36e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCR5—hypertension	1e-05	4.31e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCD—hypertension	1e-05	4.31e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCR5—hypertension	9.98e-06	4.3e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCD—hypertension	9.98e-06	4.3e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCR5—hypertension	9.88e-06	4.26e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCD—hypertension	9.88e-06	4.26e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HTR2A—hypertension	9.8e-06	4.22e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—C3—hypertension	9.78e-06	4.21e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HTR2A—hypertension	9.77e-06	4.21e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—C3—hypertension	9.75e-06	4.2e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HTR2A—hypertension	9.67e-06	4.17e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—C3—hypertension	9.66e-06	4.16e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RELA—hypertension	9.53e-06	4.1e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDGFB—hypertension	9.52e-06	4.1e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDGFB—hypertension	9.49e-06	4.09e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGFR1—hypertension	9.47e-06	4.08e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARG—hypertension	9.46e-06	4.07e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGFR1—hypertension	9.44e-06	4.07e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDGFB—hypertension	9.4e-06	4.05e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGFR1—hypertension	9.35e-06	4.03e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MTOR—hypertension	9.34e-06	4.02e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HIF1A—hypertension	9.33e-06	4.02e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—POMC—hypertension	9.33e-06	4.02e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HIF1A—hypertension	9.3e-06	4.01e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AGT—hypertension	9.3e-06	4e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—INS—hypertension	9.28e-06	4e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AGT—hypertension	9.27e-06	3.99e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HIF1A—hypertension	9.21e-06	3.97e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AGT—hypertension	9.18e-06	3.95e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CALM1—hypertension	9.14e-06	3.94e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CALM1—hypertension	9.11e-06	3.93e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOE—hypertension	9.11e-06	3.92e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LEP—hypertension	9.11e-06	3.92e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LEP—hypertension	9.08e-06	3.91e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOE—hypertension	9.08e-06	3.91e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CAV1—hypertension	9.03e-06	3.89e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CALM1—hypertension	9.02e-06	3.89e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOA1—hypertension	9e-06	3.88e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CAV1—hypertension	9e-06	3.88e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOE—hypertension	8.99e-06	3.87e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LEP—hypertension	8.99e-06	3.87e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CXCL8—hypertension	8.98e-06	3.87e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOA1—hypertension	8.98e-06	3.87e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KDR—hypertension	8.92e-06	3.84e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CAV1—hypertension	8.91e-06	3.84e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KDR—hypertension	8.9e-06	3.83e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOA1—hypertension	8.89e-06	3.83e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KDR—hypertension	8.81e-06	3.79e-05	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—AKT1—hypertension	8.67e-06	3.74e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FN1—hypertension	8.59e-06	3.7e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—F2—hypertension	8.59e-06	3.7e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCB—hypertension	8.59e-06	3.7e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FN1—hypertension	8.56e-06	3.69e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCB—hypertension	8.56e-06	3.69e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—F2—hypertension	8.56e-06	3.69e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—hypertension	8.54e-06	3.68e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ALB—hypertension	8.51e-06	3.66e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCB—hypertension	8.48e-06	3.65e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—F2—hypertension	8.48e-06	3.65e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FN1—hypertension	8.48e-06	3.65e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOTCH1—hypertension	8.41e-06	3.62e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOTCH1—hypertension	8.38e-06	3.61e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOTCH1—hypertension	8.3e-06	3.57e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—NOS3—hypertension	8.14e-06	3.5e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3R1—hypertension	8.14e-06	3.5e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MMP9—hypertension	8.12e-06	3.5e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDKN1A—hypertension	8.09e-06	3.49e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PTEN—hypertension	8.07e-06	3.48e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAPK8—hypertension	7.9e-06	3.4e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—AKT1—hypertension	7.88e-06	3.39e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—POMC—hypertension	7.83e-06	3.37e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—POMC—hypertension	7.8e-06	3.36e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—INS—hypertension	7.78e-06	3.35e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—INS—hypertension	7.76e-06	3.34e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—POMC—hypertension	7.72e-06	3.33e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EP300—hypertension	7.7e-06	3.32e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—INS—hypertension	7.68e-06	3.31e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL2—hypertension	7.66e-06	3.3e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL2—hypertension	7.63e-06	3.29e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL2—hypertension	7.56e-06	3.26e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1—hypertension	7.53e-06	3.24e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT2—hypertension	7.52e-06	3.24e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1—hypertension	7.5e-06	3.23e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT2—hypertension	7.5e-06	3.23e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—EGFR—hypertension	7.49e-06	3.23e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SRC—hypertension	7.49e-06	3.22e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—EGFR—hypertension	7.47e-06	3.22e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTGS2—hypertension	7.44e-06	3.21e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1—hypertension	7.43e-06	3.2e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT2—hypertension	7.42e-06	3.2e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—EGFR—hypertension	7.39e-06	3.18e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—VEGFA—hypertension	7.29e-06	3.14e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SERPINE1—hypertension	7.15e-06	3.08e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SERPINE1—hypertension	7.13e-06	3.07e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SERPINE1—hypertension	7.06e-06	3.04e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGF2—hypertension	6.92e-06	2.98e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGF2—hypertension	6.9e-06	2.97e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RHOA—hypertension	6.9e-06	2.97e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RHOA—hypertension	6.87e-06	2.96e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGF2—hypertension	6.83e-06	2.94e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3R1—hypertension	6.82e-06	2.94e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOS3—hypertension	6.82e-06	2.94e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RHOA—hypertension	6.81e-06	2.93e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOS3—hypertension	6.8e-06	2.93e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3R1—hypertension	6.8e-06	2.93e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3R1—hypertension	6.74e-06	2.9e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOS3—hypertension	6.74e-06	2.9e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MYC—hypertension	6.71e-06	2.89e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TGFB1—hypertension	6.69e-06	2.88e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EGFR—hypertension	6.56e-06	2.83e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTEN—hypertension	6.49e-06	2.8e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RELA—hypertension	6.42e-06	2.77e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RELA—hypertension	6.4e-06	2.76e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RELA—hypertension	6.34e-06	2.73e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MTOR—hypertension	6.3e-06	2.71e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MTOR—hypertension	6.28e-06	2.7e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MTOR—hypertension	6.22e-06	2.68e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—EP300—hypertension	6.19e-06	2.67e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CXCL8—hypertension	6.05e-06	2.61e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CXCL8—hypertension	6.03e-06	2.6e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CXCL8—hypertension	5.98e-06	2.57e-05	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT1—hypertension	5.85e-06	2.52e-05	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT1—hypertension	5.83e-06	2.51e-05	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT1—hypertension	5.77e-06	2.49e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—hypertension	5.76e-06	2.48e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—hypertension	5.74e-06	2.47e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—hypertension	5.68e-06	2.45e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TP53—hypertension	5.51e-06	2.37e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MMP9—hypertension	5.48e-06	2.36e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MMP9—hypertension	5.46e-06	2.35e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN1A—hypertension	5.46e-06	2.35e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTEN—hypertension	5.44e-06	2.34e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN1A—hypertension	5.44e-06	2.34e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTEN—hypertension	5.43e-06	2.34e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MMP9—hypertension	5.4e-06	2.33e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN1A—hypertension	5.39e-06	2.32e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTEN—hypertension	5.37e-06	2.31e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK8—hypertension	5.32e-06	2.29e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT1—hypertension	5.31e-06	2.29e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK8—hypertension	5.31e-06	2.29e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT1—hypertension	5.29e-06	2.28e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK8—hypertension	5.26e-06	2.26e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT1—hypertension	5.24e-06	2.26e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EP300—hypertension	5.19e-06	2.24e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EP300—hypertension	5.17e-06	2.23e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EP300—hypertension	5.12e-06	2.21e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SRC—hypertension	5.05e-06	2.17e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—hypertension	5.04e-06	2.17e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SRC—hypertension	5.03e-06	2.17e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SRC—hypertension	4.98e-06	2.15e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—VEGFA—hypertension	4.92e-06	2.12e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—VEGFA—hypertension	4.9e-06	2.11e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—VEGFA—hypertension	4.85e-06	2.09e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT1—hypertension	4.65e-06	2e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MYC—hypertension	4.52e-06	1.95e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TGFB1—hypertension	4.51e-06	1.94e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MYC—hypertension	4.51e-06	1.94e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TGFB1—hypertension	4.5e-06	1.94e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MYC—hypertension	4.47e-06	1.92e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TGFB1—hypertension	4.45e-06	1.92e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EGFR—hypertension	4.42e-06	1.91e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EGFR—hypertension	4.41e-06	1.9e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EGFR—hypertension	4.37e-06	1.88e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKT1—hypertension	3.74e-06	1.61e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TP53—hypertension	3.71e-06	1.6e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TP53—hypertension	3.7e-06	1.6e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TP53—hypertension	3.67e-06	1.58e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—hypertension	3.4e-06	1.46e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—hypertension	3.39e-06	1.46e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—hypertension	3.36e-06	1.45e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT1—hypertension	3.14e-06	1.35e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT1—hypertension	3.13e-06	1.35e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT1—hypertension	3.1e-06	1.33e-05	CbGpPWpGaD
